Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Ascites”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Ended earlyNCT01262612
What this trial is testing

Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion

Who this might be right for
Malignant AscitesMalignant Pleural Effusion
Radboud University Medical Center 12
Early research (Phase 1)Not Yet RecruitingNCT07615894
What this trial is testing

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

Who this might be right for
Advanced Solid TumorsMalignant Pleural EffusionsMalignant Ascites
WestVac Biopharma Co., Ltd. 9
Early research (Phase 1)UnknownNCT01852409
What this trial is testing

Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Peking University 18
Very early researchNot Yet RecruitingNCT07657416
What this trial is testing

NK521 in the Treatment of Advanced Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Ovarian CancerMalignant Ascites
Base Therapeutics (Shanghai) Co., Ltd. 18
Testing effectiveness (Phase 2)Ended earlyNCT02501213
What this trial is testing

Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)

Who this might be right for
Cancer
Centre Oscar Lambret 14
Testing effectiveness (Phase 2)Study completedNCT01065246
What this trial is testing

Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites

Who this might be right for
Malignant Ascites Due to Epithelial Carcinoma
Neovii Biotech 8
Testing effectiveness (Phase 2)Looking for participantsNCT07435701
What this trial is testing

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Who this might be right for
Ovarian Neoplasms MalignantAscites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Not applicableUnknownNCT02724683
What this trial is testing

Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.

Who this might be right for
Malignant Ascites
Maciej Stukan, MD, PhD 170
Testing effectiveness (Phase 2)Looking for participantsNCT06433869
What this trial is testing

The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites

Who this might be right for
Malignant Ascites
Sun Yat-sen University 60
Not applicableUnknownNCT03550690
What this trial is testing

Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis

Who this might be right for
Ascites, Malignant
Gloucestershire Hospitals NHS Foundation Trust 20
Not applicableActive Not RecruitingNCT04326946
What this trial is testing

International Alfapump Cohort Study

Who this might be right for
Liver CirrhosesMalignant Ascites
Sequana Medical N.V. 400
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03550560
What this trial is testing

EUS-Guided Drainage of Refractory Malignant Ascites

Who this might be right for
Malignant Ascites
Hospital Universitario Virgen Macarena 100
Testing effectiveness (Phase 2)Looking for participantsNCT03020979
What this trial is testing

A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites

Who this might be right for
Malignant AscitesApatinib
The First Affiliated Hospital of Bengbu Medical University 120
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Not applicableStudy completedNCT03200106
What this trial is testing

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

Who this might be right for
Malignant Ascites
Sequana Medical N.V. 17
Testing effectiveness (Phase 2)UnknownNCT06046963
What this trial is testing

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerPeritoneal MetastasesAscites, Malignant
Zhejiang Cancer Hospital 35
Testing effectiveness (Phase 2)UnknownNCT05501340
What this trial is testing

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Who this might be right for
Malignant Ascites
Second Affiliated Hospital of Soochow University 40
Next Page